Mon - Fri 08:00 - 21:00 GMT+3 +44 7788

Why Invest

OVITAL INTERNATIONAL is a global, innovative medical and healthcare company whose purpose is to enable healthier lives everywhere, every day. We are a champion of preserving health and have true potential in developing/integrating/partnering clear industry-leading products in each of the categories we operate: prediction – prevention – care remedy with more diverse revenue and growth drivers, than ever before.

As we grow, we not only plan to extend our blueprint services to US, Gulf countries and Europe but also reinvest in our methods/ tools and surely in people, our business, and initiatives to broadly elevate human health and well-being; enabling OVITAL to impact more and more on healthy, risky and patient lives, realize long-term success and deliver long-term shareholder value.

Our values and future vision should match with you as an investor. So please apply for a one-on-one meeting with OVITAL Representative

E mail queries to subject INVESTOR  one on one

We are unique for our exclusive services:

  • Prediction- Prevention- Treatment Protocols (including The Gonzalez Protocol)
  • Blueprint Longevity Protocols
  • Body Quantum Scoring/mapping
  • Microbiome analysis and interventions
  • Probiotic/prebiotic supplement R&D and Manufacturing
  • Autonomic Nervous System Biologic Factory setting interventions
  • Heart-Mind Regulations (tangible scientific tools)
  • AI assisted personal health coaching

Spending on unconventional medicine

The NHIS did not include questions on spending on health care, but the report authors cited spending figures from national surveys conducted in 1997. Those surveys found that:1,2

  • The U.S. public spent an estimated $36 billion to $47 billion on CAM therapies in 1997.
  • Of this amount, between $12 billion and $20 billion was paid out-of-pocket for the services of professional CAM health care providers.
  • These fees represented more than the public paid out-of-pocket for all hospitalizations in 1997 and about half of what it paid for all out-of-pocket physician services.
  • $5 billion of out-of-pocket spending was on herbal products.

1Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA. 1998;280(18):1569-1575.

2Centers for Medicare & Medicaid Services. 1997 National Health Expenditures Survey. Centers for Medicare & Medicaid Services Web site. Available at

The global complementary and alternative medicine market was valued at USD 82.78 billion in 2020 and is expected to grow at a CAGR of 21.9% during the forecast period. The market is expected to grow in the coming years as a result of the evolving regulatory landscape and strong government initiatives, resulting in the creation of strong transnational links through healing channels that bind global, national, and local movements in unconventional medicine.